ASGCT年会是全球最大规模的基因和细胞治疗领域学术会议,为与会者介绍最新基因与细胞治疗的发展以及围绕相关议题进行讨论的国际平台。 会议信息: 会议名称 第27届美国基因与细胞治疗学会年会 The 27th Annual Meeting of American Society of Gene & Cell Therapy 举办时间 2024年5月7日-11日(美国东部时间) 举办地点 ...
December 19, 2023 The primary professional membership organization for gene and cell therapy’s annual meeting. Originally designed as a venue for academic researchers to share their work, the Annual Meeting has grown to serve a wide community encompassing clinicians, bio-industry development, regulator...
October 10, 2022 The primary professional membership organization for gene and cell therapy’s annual meeting. Originally designed as a venue for academic researchers to share their work, the Annual Meeting has grown to serve a wide community encompassing clinicians, bio-industry development, regulatory...
/纽福斯公纽福斯公布布NFS-01临床试验积极数据临床试验积极数据152022 AGSCT Annual Meeting Abstracts,公司官网,华创证券纽福斯在ASGCT2022年会上发表了题为“Safety and Efficacy of First China Manufactured Gene Replacement for Lebers Hereditary Optic Neuropathy”的摘要,报道了国内首个基因治疗LHON的安全性和有效性...
信息来源: ASGCT 27th Annual Meeting Abstractsannualmeeting.asgct.org/abstracts/abstract-details?abstractId=59125编辑于 2024-04-25 12:01・IP 属地美国・信息来源于 官方网站 地中海贫血 β地中海贫血 细胞与基因治疗 赞同2添加评论 分享喜欢收藏申请转载 ...
Aanastra, Inc. announced multiple presentations at the 2024 American Society for Gene and Cell Therapies, taking place May 7-11, 2024, in Baltimore, MD.
信息来源:Abstract Details(ASGCT 27th Annual Meeting Abstracts) 发布于 2024-04-24 17:35・IP 属地美国・信息来源于 官方网站 血友病 细胞与基因治疗 赞同1添加评论 分享喜欢收藏申请转载
line Therapeutics, an innovation-driven gene therapy company dedicated to developing unique and novel solutions to address unmet needs in rare and severe diseases, presents data of multiple novel AAV gene therapy programs at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting....
ASGCT 22nd Annual Meeting 2019The American Society of Gene and Cell Therapy Annual Meeting was held between 29th April - 2nd May 2019, and focused on new developments and advancements in the field of gene and cell therapy research over the last year. The Editor-in-Chief of Gene Therapy, in...
and autoimmune diseases, today announced that a late-breaking abstract featuring preclinical data from its FT522 program for autoimmune diseases will be featured at the American Society of Gene and Cell Therapy (ASGCT) 27thAnnual Meeting, being held in Baltimore, Maryland on May 7-11, 2024. ...